Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SFM | Common Stock, par value $0.001 per share | Award | $0 | +98.6K | +70.05% | $0.00 | 239K | Mar 15, 2025 | Direct | F1 |
transaction | SFM | Common Stock, par value $0.001 per share | Sale | -$6.86M | -49.9K | -20.85% | $137.42 | 189K | Mar 17, 2025 | Direct | F2 |
transaction | SFM | Common Stock, par value $0.001 per share | Sale | -$401K | -2.92K | -1.54% | $137.48 | 187K | Mar 18, 2025 | Direct | F3, F4 |
transaction | SFM | Common Stock, par value $0.001 per share | Sale | -$409K | -2.92K | -1.56% | $140.22 | 184K | Mar 19, 2025 | Direct | F3, F5, F6 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | On March 15, 2022, the reporting person was granted performance share awards covering 66,617 shares of the Issuer's common stock at the target performance level, zero to 200% of which would become eligible to vest based on the achievement of 2024 performance goals as certified by the Issuer's compensation committee. Following certification of achievement of the performance criteria for fiscal 2024 by the Issuer's compensation committee at the 148% performance level, 98,593 shares vested on March 15, 2025. |
F2 | This transaction was a broker-assisted sale of shares of common stock to satisfy the withholding tax liability incurred upon the vesting of restricted stock units and performance share awards, as mandated by the Issuer's election under its equity incentive plan documents, and does not represent a discretionary trade by the reporting person. |
F3 | This transaction was pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
F4 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.94 to $139.285 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F5 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.23 to $142.035 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F6 | Includes 156,869 shares of common stock and 26,750 restricted stock units. Each restricted stock unit represents the right to receive, upon vesting, one share of common stock. 11,556 restricted stock units will vest on March 14, 2026 and 15,194 restricted stock units will vest evenly over two years on March 19, 2026 and March 19, 2027. All such vests assume continued employment through the applicable vest date. |